Foam: Rediscovered Drug Form

September 2020 in “ Farmacja Polska ”

Dorota Haznar-Garbacz

foam topical skin treatments drug absorption drug solubility parenteral applications sustained drug release

Studysummary This review discusses various applications of foam systems in drug form technology, highlighting their potential to enhance drug solubility and release modifications, but reports no new clinical results.

Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer

The document reviewed the use of foam as a drug form, highlighting its advantages in drug delivery systems. Foams, being multiphase systems, were noted for their high surface area and low density, which enhanced drug absorption and solubility. Initially used for topical skin treatments, foams were well-received by patients and showed better absorption than ointments. The review discussed the potential of foams in oral medications, where they could increase drug solubility and modify release by holding drugs in their pores. Additionally, foams were used in parenteral applications, such as bone implants and antibiotic carriers, due to their ability to remain longer in the gastrointestinal tract and provide sustained drug release.

View this study on doi.org →

Discuss this study in the Community →

Research cited in this study

4 / 4 results

research Effect of Minoxidil Topical Foam on Frontotemporal and Vertex Androgenetic Alopecia in Men: A 104-Week Open-Label Clinical Trial

20 citations , September 2015 in “Journal of The European Academy of Dermatology and Venereology”

This study found that 5% minoxidil topical foam was effective in stabilizing hair density and scalp coverage in men with moderate androgenetic alopecia over 104 weeks, with good safety and tolerability.

A Randomized, Single-Blind Trial of 5% Minoxidil Foam Once Daily Versus 2% Minoxidil Solution Twice Daily in the Treatment of Androgenetic Alopecia in Women

research A Randomized, Single-Blind Trial of 5% Minoxidil Foam Once Daily Versus 2% Minoxidil Solution Twice Daily in the Treatment of Androgenetic Alopecia in Women

100 citations , June 2011 in “Journal of The American Academy of Dermatology”

This study found that a once-daily 5% minoxidil topical foam is as effective as a twice-daily 2% minoxidil topical solution for hair growth in women with androgenetic alopecia, with fewer side effects and greater styling convenience.

research Follicular and Percutaneous Penetration Pathways of Topically Applied Minoxidil Foam

74 citations , June 2010 in “European Journal of Pharmaceutics and Biopharmaceutics”

This study found that hair follicles are a significant and efficient pathway for the absorption of topical minoxidil foam in humans, with faster blood detection when follicles are open.

research The Effects of Particle Properties on Nanoparticle Drug Retention and Release in Dynamic Minoxidil Foams

25 citations , January 2010 in “International Journal of Pharmaceutics”

This study found that polymeric nanoparticles retained more minoxidil and facilitated superior drug permeation compared to lipid nanoparticles, although premature drug release affected formulation performance.